Clinical Trials Cultivation Extraction 
Cannabis Law Report
JULY 24, 2021
The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.
Veriheal
MARCH 2, 2024
The revised legislation would permit clinical use and production of cannabis for medical CBD products, like Epidiolex , that have been approved in the U.S. The changes that allow for the cultivation and production of CBD in Japan will further support the country’s existing CBD market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 19, 2021
Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed. “We have real expertise in cultivation and extraction in this country,” she added in a report published by drug reform group Volteface.
Cannabis Law Report
MAY 29, 2019
The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research. Here’s the press release.
Cannabis Law Report
SEPTEMBER 12, 2022
All Optimi mushroom products are grown from the Company’s world-leading psilocybin genetic bank and are grown in EU-GMP compliant clean rooms that ensure sterile cultivation and undergo almost 300 different analytical tests post-harvest. The harvest includes the following psilocybin-containing mushroom strains: Koh Samui.
Cannabis Law Report
DECEMBER 14, 2019
The new law is set to go into effect in 2020 and allows individuals over 18 to possess up to 50 grams of dried flower and cultivate two cannabis plants in their home, with a maximum of four plants per residence. There’s also EcoFibre (ASX: EOF ), which boasts a market capitalisation of AU$1 billion. Learn to profit from cannabis companies.
The Cannigma
MARCH 15, 2021
The Syqe inhaler was developed in Israel through several clinical trials , which found that measured, uniform doses can be a safe and efficient way to treat chronic pain. If it wasn’t obvious, the Syqe inhaler isn’t the sort of device you’ll find at your head shop next to the dab rigs and Polar Bear Snuff. Is it a bong? sorta both?
Expert insights. Personalized for you.
105 
Let's personalize your content